International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-4 : 283-289 doi: 10.5281/zenodo.16729283
Original Article
Vitamin D Levels in Children Aged 1-12 Years on Anti Epileptic Drugs
 ,
 ,
Published
Aug. 2, 2025
Abstract

Vitamin D is an essential nutrient which has pivotal role in calcium homeostasis. bone mineral metabolism and fundamental biological functions. Also vitamin D is known to have anti epileptogenic activity and hence its deficiency in children with seizure disorder is associated with difficulty in seizure control. It has been postulated that AEDs result in low vitamin D levels by varying mechanisms. Our study aims to find out the relation between AEDs and vitamin D levels.

OBJECTIVES

  1. To estimate the levels of vitamin D in children on Antiepileptic drugs.
  2. To study the associated risk factors of vitamin D deficiency in children on Antiepileptic drugs.

                                      

MATERIALS AND METHODS: A cross sectional study done in 100 children aged 1-12 years on AEDs for >1 year. Vitamin D levels along with type of AEDs used were assessed. Vitamin D deficiency classified according to U S Endocrine society classification.

RESULTS: Vitamin D deficiency was found in 74 %, 15% had insufficiency and 11 % had sufficiency.  Patient on Monotherapy 84% and polytherapy 16 % although not associated with vitamin D deficiency. Vitamin D deficiency associated with longer duration of anticonvulsant, shorter seizure free period, developmental delay, increased BMI.

CONCLUSIONS: Vitamin D deficiency was prevalent (74%) among our study subjects on antiepileptic drugs. It was observed that vitamin D deficiency was significantly associated with duration of antiepileptic, seizure free period, BMI and developmental delay.

Vitamin D deficiency in our study was found in both enzyme inducing and non enzyme inducing antiepileptic drug usage.

Recommended Articles
Loading Image...
Volume-6, Issue-4
Citations
2640 Views
45 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved